Navigation Links
Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Date:9/14/2007

Event for Congressional Members and Staff Will Focus on Advances in

Research and Treatment of Lung Cancer in Women

SEATTLE, Sept. 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX:), along with the Society for Women's Health Research, the Lung Cancer Alliance and others, will sponsor a panel discussion entitled "Lung Cancer: Being Female Matters to Research," on Capitol Hill to discuss advances in the research and treatment of lung cancer in women on Monday, September 17.

CTI has been conducting clinical trials of its investigational drug, XYOTAX(TM), researching how estrogen levels affect a woman's response to treatment for lung cancer. Data collected from recent XYOTAX trials suggests that estrogen levels may alter the effectiveness of cancer treatment, and that women with higher levels of estrogen had a lower rate of survival in cases of lung cancer.

The event will be held in room B-340 of the Rayburn House Office Building from noon to 1:30 p.m. Speakers will include Laurie Fenton Ambrose, President of the Lung Cancer Alliance, Joan H. Schiller, M.D., Chief of Hematology and Oncology at the University of Texas Southwestern Medical Center and Deputy Director of Simmons Comprehensive Cancer Center, and Jill M. Siegfried, Ph.D., Professor and Vice Chair of Pharmacology at the University of Pittsburgh School of Medicine and co-Director of the Lung and Esophageal Cancer Program at the University of Pittsburgh Cancer Institute (UPCI).

Women and Lung Cancer

Lung cancer is the number one cancer killer of women in the United States -- more than breast and ovarian cancers combined. The American Cancer Society estimates that in 2007 there will be approximately 213,490 new cases of lung cancer in the United States -- up 22 percent from 2006. Of those new cases, 98,620 will be among women -- up 20 percent from a year ago. One in 16 women will develop lung cancer in their lifetime.

"Gende
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
4. Analyzers Offer Point-of-Care Lipid Panels
5. 2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion
6. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
7. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
8. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
9. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... DALLAS , July 24, 2014 /PRNewswire-iReach/ -- ... days once order is placed. Photo ... is a professional and in-depth market survey on ... firstly reviews the basic information of Hemodialysis Machine ... report then explores global and China,s top manufacturers ...
(Date:7/24/2014)... Cancer patients in the west of ... closer to home when a new radiotherapy center opens near ... (NYSE: VAR ) has been selected to equip ... for four TrueBeam™ medical linear accelerators. Two ... radiotherapy and radiosurgery treatments, will replace older treatment machines at ...
(Date:7/24/2014)...  Blueprint Medicines (Blueprint), a leader in discovering highly ... announced the appointment of Jeffrey Albers as ... Algeta ASA, where he served on the executive management ... Bayer. Mr. Albers succeeds Alexis Borisy , co-founder ... Rock Ventures, who will remain an active member of ...
Breaking Medicine Technology:Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer 2
... ATLANTA, May 30, 2012 Advanced automation, sophisticated eScribe ... portal are among the new innovations showcased in Elekta,s ... of Clinical Oncology (ASCO) Annual Meeting, June 1-4, at ... for the sixth consecutive year, Elekta (booth #4019) ...
... 30, 2012  Actavis Group, an international generic pharmaceuticals ... approval of Nifedipine Extended-Release Tablets, USP, 90mg, a ... the product has commenced.  Nifedipine ... $23 million for the 12 months ending December ...
Cached Medicine Technology:Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting 2Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting 3Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP) 2
(Date:7/24/2014)... all prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged ... the United States. Many children with this abnormality ... first few years of life with the hopes ... Until recently, however, little evidence existed as to ... cost and inconvenience for families. But a study ...
(Date:7/24/2014)... The North American air and missile defense radar ... is expected to register a CAGR of 8.22% to reach ... market for the air and missile defense radar system. However, ... budget cuts as well. , Browse through the TOC of ... to get an idea of the in-depth analysis provided. This ...
(Date:7/24/2014)... Aristotle said, "Love is composed of a single soul ... you and your partner were made in heaven for ... study. , Psychologists observe that people talk and ... such diversity are some common themes that frame how ... considers love as perfect unity ("made for each other," ...
(Date:7/24/2014)... Washington, DC (PRWEB) July 24, 2014 ... pleased to announce the launch of a new version ... Interview Scheduling Manager, or PRISM, for applicants participating in ... PRISM permits applicants to track and organize program information ... summaries in advance of creating their rank order lists. ...
(Date:7/24/2014)... DC (PRWEB) July 24, 2014 ... problem of prescription non-adherence at Cardinal Health RBC ... 26th. Utilizing familiar and user-friendly Mobile devices, RxNetwork ... and payers. , Already embraced by over ... motivating patients and caregivers through timely alerts and ...
Breaking Medicine News(10 mins):Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 2Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 4Health News:New research: When it hurts to think we were made for each other 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 3Health News:RxNetwork Brings the Next Generation Customer Care Connectivity to Pharmacies, Providers, and Patients 2
... adults are being diagnosed with type 2 diabetes and now ... greater risk for a heart attack and stroke. //Specifically, the ... 14-times more likely to suffer a heart attack and 30-times ... diabetes. ,"This means that huge numbers of people are ...
... cancer patients who receive radiation therapy after undergoing ... likely to develop complications.// However, a new study ... ,Researchers from the Fox Chase Cancer Center studied ... mastectomy, breast reconstruction, and postoperative radiation between 1987 ...
... Doctors may have a new tool to help acne patients. ... for acne sufferers. //This is important because this skin disease ... and sometimes even suicide. ,Doctors from London recruited 41 ... patients received one treatment of the pulsed-dye laser. The other ...
... have far more to be concerned about than only their ... kidney disease are in the highest risk group for heart ... also applies to people who are in the very early ... in end-stage renal disease have a greater risk of heart ...
... will put almost anything in their mouths. But as ... they eat,// particularly if they have not tried it ... troublesome.But scientists say thousands of years ago toxins in ... high risk of food poisoning.,So it makes sense that ...
... help ward off obesity as children get older.// ... long-term data available on breastfeeding and weight of ... aimed at clarifying the situation. In both, investigators ... to see how breastfeeding impacts weight. Detailed breastfeeding ...
Cached Medicine News:
... heavy duty, controlled stretch knee support that ... allowing full range of motion. The ... the knee, and help to keep the ... This is an excellent support for ...
... breathable foam. Three piece design for precise ... loop closures. Lightweight rigid posterior stays with ... with optional hot and cold therapy Gel ... pain cycle by providing cold therapy to ...
... Scoring: , One of the outstanding features ... our patented Three-Dimensional Molding Technology. , This ... brace which effectively controls the bunching and ... comfort to the wearer. , ...
... new padding system from Innovation Sports. Exceptionally ... contours to the unique anatomy of each ... Gel Fit's proprietary Octogrip™ Anti-Slip System improves ... when the brace is strapped on. Gel ...
Medicine Products: